Conmed (CNMD) Tops Q1 EPS by 5c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Boeing free cash flow beats estimates despite production challenges
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.68 --0%
Revenue Growth %: -0.5%
Financial Fact:
Net Income Basic: 0.26
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: -0.5%
Financial Fact:
Net Income Basic: 0.26
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.79, $0.05 better than the analyst estimate of $0.74. Revenue for the quarter came in at $312.3 million versus the consensus estimate of $306.73 million.
GUIDANCE:
Conmed sees FY2024 EPS of $4.25-$4.35, versus the consensus of $4.33. Conmed sees FY2024 revenue of $1.33-1.355 billion, versus the consensus of $1.35 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CTS Corp. (CTS) Tops Q3 EPS by 10c ; Offers Guidance
- S&P Global (SPGI) Tops Q3 EPS by 16c
- Illinois Tool Works (ITW) Tops Q3 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
